Welcome to LookChem.com Sign In|Join Free

CAS

  • or

121286-45-1

121286-45-1

Post Buying Request

121286-45-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

121286-45-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 121286-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,2,8 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 121286-45:
(8*1)+(7*2)+(6*1)+(5*2)+(4*8)+(3*6)+(2*4)+(1*5)=101
101 % 10 = 1
So 121286-45-1 is a valid CAS Registry Number.

121286-45-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-fluoro-2-methyl-6-propan-2-ylaniline

1.2 Other means of identification

Product number -
Other names Benzenamine,4-fluoro-2-methyl-6-(1-methylethyl)-(9CI)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121286-45-1 SDS

121286-45-1Upstream product

121286-45-1Downstream Products

121286-45-1Relevant articles and documents

OGA INHIBITOR COMPOUNDS

-

Page/Page column 68, (2020/01/11)

The present invention relates to O-GIcNAc hydrolase (OGA) inhibitors of formula (I). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which inhibition of OGA is beneficial, such as tauopathies in particular Alzheimer's disease or progressive supranuclear palsy; and neurodegenerative diseases accompanied by a tau pathology, in particular amyotrophic lateral sclerosis or frontotemporal lobe dementia caused by C90RF72 mutations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121286-45-1